T. Takami et al., DECREASED NOREPINEPHRINE CONTENT IN THE MEDULLA-OBLONGATA IN SEVERELYHYPERTENSIVE RATS, Clinical and experimental pharmacology and physiology, 20(3), 1993, pp. 161-167
1. To clarify possible abnormalities in catecholamines in the medulla
oblongata in relation to severe hypertension, the authors measured cha
nges in catecholamine levels in the medulla oblongata of malignant str
oke-prone spontaneously hypertensive rats (M-SHRSP). Effects of the ad
renal medullae and peripheral nerves were ruled out by adrenal demedul
lation and chemical sympathectomy. 2. The level of norepinephrine in t
he medulla oblongata was significantly lower in untreated M-SHRSP than
in untreated WKY (control) rats at 10 weeks of age. Further, it was s
ignificantly lower in treated M-SHRSP than in the treated WKY group at
both 6 and 10 weeks of age. The level of epinephrine in 6 week old tr
eated M-SHRSP was significantly higher than that in age-matched treate
d WKY, but no other differences were observed in terms of epinephrine
content. There were no age- or treatment-related differences in dopami
ne levels in the medulla oblongata. 3. Since norepinephrine has an inh
ibitory effect on blood pressure elevation in the nucleus tractus soli
tarii (NTS) in the medulla oblongata, the suppression of negative feed
back due to a decrease in the activity of inhibitory neurons in the me
dulla oblongata appears to be involved in the development and progress
ion of severe hypertension in M-SHRSP.